145 related articles for article (PubMed ID: 25731407)
1. [A long-term survivor of cT4 esophageal carcinoma treated via a multimodal approach - a case report].
Ikai A; Fujiwara H; Shiozaki A; Konishi H; Kosuga T; Komatsu S; Ichikawa D; Okamoto K; Morimura R; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Otsuji E
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2016-8. PubMed ID: 25731407
[TBL] [Abstract][Full Text] [Related]
2. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
3. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
[TBL] [Abstract][Full Text] [Related]
4. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
[TBL] [Abstract][Full Text] [Related]
5. [A case of advanced esophageal cancer with direct bronchial invasion successfully treated by multidisciplinary therapy].
Haba Y; Okamoto K; Watanabe T; Tsukada T; Kinoshita J; Makino I; Nakamura K; Oyama K; Ninomiya I; Fushida S; Fujimura T; Ohta T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2019-20. PubMed ID: 25731408
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Myocardial Metastasis of Esophageal Squamous Cell Carcinoma].
Muroya T; Wajima N; Yachi T; Akaishi T; Umetsu S; Yoshida T; Wakasa Y; Sato K; Mitsuhashi Y; Umemura K; Suzuki T; Tsuruta S; Hakamada K
Gan To Kagaku Ryoho; 2018 Feb; 45(2):333-335. PubMed ID: 29483438
[TBL] [Abstract][Full Text] [Related]
8. [Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the Trachea and Carotid Artery after Chemoradiotherapy - A Case Report].
Odagiri K; Yamazaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2006-2008. PubMed ID: 29394849
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy].
Kano K; Sato T; Maezawa Y; Segami K; Nakajima T; Ikeda K; Hayashi T; Yamada T; Yamamoto N; Ohshima T; Yukawa N; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1262-1264. PubMed ID: 27760954
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
[TBL] [Abstract][Full Text] [Related]
13. [Salvage Surgery after CRT for Advanced Esophageal Cancer Resulting in a Pathological Complete Response and More Than Five Years' Survival].
Kaida S; Murata S; Yamaguchi T; Ohtake R; Takebayashi K; Yamamoto H; Ueki T; Miyake T; Iida H; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Tani M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2007-2009. PubMed ID: 28133204
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
16. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
[TBL] [Abstract][Full Text] [Related]
17. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
18. A second primary esophageal cancer developing 7 years after chemoradiotherapy for advanced esophageal cancer.
Suto R; Enjoji A; Okudaira S; Furui J; Matsuo T; Kanematsu T
J Gastroenterol; 2001 Jul; 36(7):495-9. PubMed ID: 11480795
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
Ishikawa Y; Suzuki M; Yamaguchi H; Seto I; Machida M; Takagawa Y; Jingu K; Kikuchi Y; Murakami M
J Med Case Rep; 2022 Feb; 16(1):68. PubMed ID: 35152904
[TBL] [Abstract][Full Text] [Related]
20. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.
Molena D; Sun HH; Badr AS; Mungo B; Sarkaria IS; Adusumilli PS; Bains MS; Rusch VW; Ilson DH; Rizk NP
Dis Esophagus; 2014; 27(4):355-9. PubMed ID: 24033404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
